Biblio Discovery — Demo Discovery Service

14 hasil untuk "Anthony P Conley"

Menampilkan 1–14 · 5,72 detik · RSS

  1. Artikel Jurnal Teks lengkap

    A tool for discovering drug sensitivity and gene expression associations in cancer cells.

    Yong Qin; Anthony P Conley; Elizabeth A Grimm dkk.

    PLoS ONE, Vol. 12 No. 4 · 2017 · Inggris · DOAJ Scopus

    The sensitivity of cancer cells to anticancer drugs is a crucial factor for developing effective treatments. However, it is still challenging to precisely predict the effectiveness of therapeutics in humans within a complex genomic and molecular context. We developed an interface which allows the…

    Juga tersedia di: PLOS

  2. Artikel Jurnal

    Disseminated Coccidioidomycosis Following COVID-19 Mimicking Metastatic Thoracic Relapse of Well-Differentiated Liposarcoma: A Case Report

    Elise F. Nassif; Nolan Maloney; Anthony P. Conley dkk.

    Frontiers in Medicine, Vol. 8 · 2021 · Inggris · DOAJ Scopus

    Introduction: COVID-19 is associated with immune dysregulation which may increase susceptibility to atypical infectious diseases, particularly in the vulnerable cancer patient population. Coccidioidomycosis is an endemic fungal infection which presents with mild-to-moderate pneumonia in most…

  3. Artikel Jurnal Teks lengkap

    Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine (18F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study

    Kalevi Kairemo; Elmer B. Santos; Homer A. Macapinlac dkk.

    Diagnostics, Vol. 10 No. 3 · 2020 · Inggris · DOAJ Scopus

    Although 3′-deoxy-3′[(18)F]-fluorothymidine (FLT)-positron emission tomography (PET) has been utilized for tumor response assessment to neoadjuvant chemotherapy in soft tissue sarcomas, it has not been exploited for the assessment of early response to systematically targeted therapies. Herein, we…

  4. Artikel Jurnal

    Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor

    Jocelyn Joseph; Michael J. Nathenson; Van Anh Trinh dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 7 No. 1 · 2019 · Inggris · DOAJ Scopus

    Abstract Background Adoptive transfer of autologous T-lymphocytes transduced with a high affinity NY-ESO-1-reactive T-cell receptor (NY-ESO-1c259 T-cells) has emerged as a promising therapeutic strategy for patients with refractory synovial sarcoma. Secondary autoimmune T-cell mediated toxicities…

  5. Artikel Jurnal

    Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels

    Franco Rubino; Christopher Alvarez-Breckenridge; Kadir Akdemir dkk.

    Frontiers in Oncology, Vol. 12 · 2022 · Inggris · DOAJ Scopus

    Introduction and objectiveDespite the improvements in management and treatment of chordomas over time, the risk of disease recurrence remains high. Consequently, there is a push to develop effective systemic therapeutics for newly diagnosed and recurrent disease. In order to tailor treatment for…

  6. Artikel Jurnal

    Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone

    Brina A. Patel; Jason T. Smith; Sintawat Wangsiricharoen dkk.

    Frontiers in Oncology, Vol. 16 · 2026 · Inggris · DOAJ Scopus

    Undifferentiated pleomorphic sarcoma of bone (UPS-B) is a rare and aggressive cancer that accounts for a small fraction of bone sarcomas. Compared to both undifferentiated pleomorphic sarcoma of soft tissue (UPS-ST) and osteosarcoma, UPS-B demonstrates lower chemosensitivity and a poorer prognosis…

  7. Artikel Jurnal

    Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort

    Michael S Nakazawa; J Andrew Livingston; Maria A Zarzour dkk.

    Rare Tumors, Vol. 16 · 2024 · Inggris · DOAJ Scopus

    Background: Rhabdomyosarcomas are the most common soft tissue sarcoma in children, and pediatric alveolar rhabdomyosarcoma (ARMS) prognosis has improved based on cooperative studies. However, in adults, ARMS is significantly rarer, has poorer outcomes, and currently lacks optimal treatment…

  8. Artikel Jurnal

    Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma

    Prapassorn Thirasastr; Heather Lin; Behrang Amini dkk.

    Cancer Medicine, Vol. 12 No. 4 · 2023 · Inggris · DOAJ Scopus

    Abstract Objective Well‐differentiated (WDLPS) and dedifferentiated liposarcoma (DDLPS) account for the majority of liposarcomas. Although gemcitabine‐docetaxel is used as second‐line treatment in soft tissue sarcomas, its efficacy in WDLPS/DDLPS is not established. This study retrospectively…

  9. Artikel Jurnal

    Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions

    David Boyce-Fappiano, MD, MHM; Ethan P. Damron, BS; Ahsan Farooqi, MD, PhD dkk.

    Advances in Radiation Oncology, Vol. 7 No. 3 · 2022 · Inggris · DOAJ Scopus

    Purpose: Given the relative radioresistance of sarcomas and their often large size, conventional palliative radiation therapy (RT) often offers limited tumor control and symptom relief. We report on our use of hypofractionated RT (HFRT) as a strategy to promote durable local disease control and…

  10. Artikel Jurnal

    Immuno-genomic landscape of osteosarcoma

    Chia-Chin Wu; Hannah C. Beird; J. Andrew Livingston dkk.

    Nature Communications, Vol. 11 No. 1 · 2020 · Inggris · DOAJ Scopus

    The efficacy of immune checkpoint inhibitors (ICI) in osteosarcoma has been limited. Here, the authors investigate the immunogenomic landscape of osteosarcoma, and integrated analyses highlight features related to a suppressed immune microenvironment.

  11. Artikel Jurnal

    Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma

    Sandra P. D’Angelo; Allison L. Richards; Anthony P. Conley dkk.

    Nature Communications, Vol. 13 No. 1 · 2022 · Inggris · DOAJ Scopus

    The activity of PD-1 blockade in patients with sarcoma has been modest so far. Here, the authors report the results of a pilot clinical trial to assess the efficacy and safety of bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, in combination with the PD1 blockade…

  12. Artikel Jurnal

    The immune landscape of undifferentiated pleomorphic sarcoma

    Rossana Lazcano; Carmelia M. Barreto; Ruth Salazar dkk.

    Frontiers in Oncology, Vol. 12 · 2022 · Inggris · DOAJ Scopus

    IntroductionUndifferentiated pleomorphic sarcoma (UPS) can be associated with a relatively dense immune infiltration. Immune checkpoint inhibitors (anti-PD1, anti-PDL1, and anti-CTLA4) are effective in 20% of UPS patients. We characterize the immune microenvironment of UPS and its association with…